You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

empagliflozin

Showing 51 - 75 of 130
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Maturity-Onset Diabetes of the Young, Type 3, Type 2 Diabetes Trial in Herlev (Hyperglycaemic clamp, Placebo, Empagliflozin)

Recruiting
  • Maturity-Onset Diabetes of the Young, Type 3
  • Type 2 Diabetes
  • Hyperglycaemic clamp
  • +2 more
  • Herlev, Denmark
    Steno Diabetes Center Copenhagen
Jun 24, 2022

Type2 Diabetes Trial in Herlev (Empagliflozin, Placebo Oral Tablet)

Completed
  • Type2 Diabetes Mellitus
  • Empagliflozin
  • Placebo Oral Tablet
  • Herlev, Denmark
    Herlev og Gentofte Hospital
Aug 17, 2022

Type 2 Diabetic Saudi Arabia Treated With Empagliflozin to

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Empagliflozin
  • Dipeptidyl-peptidase 4 (DPP-4) inhibitors
  • Abha, Saudi Arabia
  • +20 more
Feb 9, 2022

NASH, NASH - Nonalcoholic Steatohepatitis, Type 2 Diabetes Trial in Fort Myers, San Antonio (MET409 Active, MET409 Placebo,

Active, not recruiting
  • NASH
  • +7 more
  • MET409 Active
  • +2 more
  • Fort Myers, Florida
  • +1 more
May 28, 2021

Type II Diabetes Trial (PIEMONTE, PIEMONTE PLACEBO, EMPAGLIFLOZIN)

Not yet recruiting
  • Type II Diabetes
  • (no location specified)
Aug 31, 2021

Cardiovascular Diseases Trial in New York (Empagliflozin, Placebos)

Completed
Has Results
  • Cardiovascular Diseases
  • Empagliflozin
  • Placebos
  • New York, New York
    Mount Sinai Heart - Icahn School of Medicine at Mount Sinai
Mar 2, 2021

Diabetes, Type 2, Diastolic Dysfunction Trial in Mainz (Empagliflozin, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Diastolic Dysfunction
  • Empagliflozin
  • Placebo
  • Mainz, Germany
    Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Ze
Apr 16, 2021

NASH - Nonalcoholic Steatohepatitis, Diabetes, Type 2 Trial in Worldwide (IVA337, Placebo, Empagliflozin)

Recruiting
  • NASH - Nonalcoholic Steatohepatitis
  • Diabetes Mellitus, Type 2
  • Homewood, Alabama
  • +40 more
Jan 23, 2023

Diabetes, Type 2, Acute Heart Failure Trial in Aachen (Empagliflozin, Placebo)

Terminated
  • Diabetes Mellitus, Type 2
  • Acute Heart Failure
  • Empagliflozin
  • Placebo
  • Aachen, NRW, Germany
    Department of Internal Medicine I RWTH Aachen University Hospita
Mar 9, 2021

Diabetes, Type 2 Trial in Worldwide (Semaglutide, Empagliflozin, Metformin)

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Toluca Lake, California
  • +101 more
Oct 9, 2023

Type II Diabetes Trial in Pakistan (Empagliflozin, Usual care group)

Completed
  • Type II Diabetes Mellitus
  • Empagliflozin
  • Usual care group
  • Quetta, Balochistan, Pakistan
  • +10 more
Dec 10, 2020

Acromegaly, Cardiomyopathies Trial in Shanghai (Empagliflozin)

Recruiting
  • Acromegaly
  • Cardiomyopathies
  • Empagliflozin
  • Shanghai, Shanghai, China
    Huashan Hospital
Aug 17, 2020

Diabetes, Type 2 Trial (Canagliflozin, Dapagliflozin, Empagliflozin)

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • (no location specified)
Mar 10, 2021

Type 2 Diabetes, Chronic Kidney Disease Trial in Worldwide (Finerenone (Kerendia, BAY94-8862 ), Empagliflozin, Placebo)

Recruiting
  • Type 2 Diabetes Mellitus
  • Chronic Kidney Disease
  • Finerenone (Kerendia, BAY94-8862 )
  • +2 more
  • Mesa, Arizona
  • +130 more
Aug 12, 2022

Diabetes, Type 1, Diabetes, Type 2, Obesity Trial in Toronto (Empagliflozin, Placebo (matching empagliflozin), ramipril)

Completed
Has Results
  • Diabetes Mellitus, Type 1
  • +2 more
  • Empagliflozin
  • +2 more
  • Toronto, Ontario, Canada
    Toronto General Hospital
Jul 23, 2020

Diabetes, Type 2 Trial in Worldwide (Linagliptin, Empagliflozin, Placebo)

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Phoenix, Arizona
  • +82 more
Aug 23, 2022

Type 2 Diabetes Trial in Neuss (Empagliflozin, Hydrochlorothiazide 25 mg)

Completed
  • Type 2 Diabetes Mellitus
  • Empagliflozin
  • Hydrochlorothiazide 25 mg
  • Neuss, North Rhine-Westphalia, Germany
    Profil Institut für Stoffwechselforschung GmbH
Jul 13, 2020

Heart Failure, Type II; Diabetes Trial in New Haven (Empagliflozin, Placebo Oral Capsule)

Completed
  • Heart Failure
  • Type II; Diabetes
  • Empagliflozin
  • Placebo Oral Capsule
  • New Haven, Connecticut
    Yale New Haven Hospital
Jun 24, 2020

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, empagliflozin)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Tuscumbia, Alabama
  • +105 more
Jul 11, 2022

NAFLD - Nonalcoholic Fatty Liver Disease, Type2 Diabetes Trial in Seoul (Pioglitazone, Empagliflozin, Combination of

Unknown status
  • NAFLD - Nonalcoholic Fatty Liver Disease
  • Type2 Diabetes
  • Seoul, Korea, Republic of
    Yonsei University College of Medicine, Department of Internal Me
Oct 15, 2020

Patients Trial in Hackensack (Empagliflozin, Dorzagliatin)

Completed
  • Patients
  • Hackensack, New Jersey
    Frontage Clinical Services Inc.
Mar 24, 2020

Healthy Trial in Biberach (Empagliflozin/linagliptin/metformin HCl, Empagliflozin, Linagliptin)

Completed
Has Results
  • Healthy
  • Empagliflozin/linagliptin/metformin HCl
  • +3 more
  • Biberach, Germany
    Humanpharmakologisches Zentrum Biberach
Feb 25, 2020

Kidney Disease, Chronic Trial in Worldwide (BI 690517, Placebo to BI 690517, Empagliflozin)

Recruiting
  • Kidney Disease, Chronic
  • BI 690517
  • +3 more
  • Mesa, Arizona
  • +175 more
Aug 23, 2022

Type2 Diabetes Trial in Seoul (Glimepiride, Empagliflozin)

Completed
  • Type2 Diabetes Mellitus
  • Seoul, Korea, Republic of
    Yonsei University College of Medicine, Department of Internal Me
Aug 24, 2020

Healthy Trial in Biberach (Empagliflozin, Metformin HCl, Linagliptin (fixed dose combination), Empagliflozin, Linagliptin)

Completed
Has Results
  • Healthy
  • Empagliflozin, Metformin HCl, Linagliptin (fixed dose combination)
  • +3 more
  • Biberach, Germany
    Humanpharmakologisches Zentrum Biberach
Feb 6, 2020